Design Therapeutics (DSGN) Research & Development (2020 - 2026)
Design Therapeutics (DSGN) posted Research & Development of $16.39 million for Q2 2026, up 4.1% from $15.74 million a year earlier and up 14.0% from the prior quarter.
Powered by 
Analysis
Design Therapeutics (DSGN) Research & Development (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Design Therapeutics was $58.78 million, up 6.6% year-over-year; for FY2025, it was $59.13 million, up 33.3% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 57.7% (FY2020 to FY2025).
- In prior years, Design Therapeutics' Research & Development was $44.35 million in FY2024 (-22.3%), $57.06 million in FY2023 (+17.4%), $48.61 million in FY2022 (+96.2%) and $24.78 million in FY2021 (+308.9%).
- The Q2 2026 figure stands as the highest quarterly Research & Development since Q2 2023.
- On a year-over-year basis, Research & Development increased in six of the last eight quarters, with growth averaging 17.2%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q3 2021, with growth of 346.1%; the weakest was Q2 2024, with a decline of 38.4%.
- According to Business Quant data, Research & Development for the three prior quarters was $14.38 million (Q1 2026), $13.43 million (Q4 2025) and $14.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Design Therapeutics | 678.89 Mn | -179.78 Mn | - | 16.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 16.93 Mn |
| Jun 30, 2026 | 16.39 Mn |
| Mar 31, 2026 | 14.38 Mn |
| Dec 31, 2025 | 13.43 Mn |
| Sep 30, 2025 | 14.59 Mn |
| Jun 30, 2025 | 15.74 Mn |
| Mar 31, 2025 | 15.38 Mn |
| Dec 31, 2024 | 12.16 Mn |
| Sep 30, 2024 | 11.88 Mn |
| Jun 30, 2024 | 10.52 Mn |
| Mar 31, 2024 | 9.80 Mn |
| Dec 31, 2023 | 11.01 Mn |
| Sep 30, 2023 | 13.26 Mn |
| Jun 30, 2023 | 17.06 Mn |
| Mar 31, 2023 | 15.73 Mn |
| Dec 31, 2022 | 14.26 Mn |
| Sep 30, 2022 | 14.30 Mn |
| Jun 30, 2022 | 11.30 Mn |
| Mar 31, 2022 | 8.76 Mn |
| Dec 31, 2021 | 7.34 Mn |
API Access
Design Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=DSGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "DSGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=DSGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();